Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Different vasodilating mechanisms--different peripheral effects?

A Breckenridge1, D Roberts, T Walley

  • 1Department of Pharmacology and Therapeutics, University of Liverpool, England.

Journal of Cardiovascular Pharmacology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory Consequences of "Brexit" for the Development of Medicinal Products.

Clinical pharmacology and therapeutics·2017
Same author

Regulatory review: How do agencies ensure the quality of decision making?

Clinical pharmacology and therapeutics·2013
Same author

Advancing the science of medicines regulation: the role of the 21st-century medicines regulator.

Clinical pharmacology and therapeutics·2012
Same author

The challenges of orphan drugs and orphan diseases: real and imagined.

Clinical pharmacology and therapeutics·2012
Same author

Interactions with warfarin.

British journal of clinical pharmacology·2012
Same author

European perspective on risk management and drug safety.

Clinical pharmacology and therapeutics·2011
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
Same journal

The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

Journal of cardiovascular pharmacology·2026
Same journal

Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.

Journal of cardiovascular pharmacology·2026
See all related articles

Researchers compared how antihypertensive drugs affect limb blood flow in patients with hypertension and peripheral vascular disease. Further studies are needed to understand the effects of new drugs like carvedilol.

Area of Science:

  • Cardiovascular Science
  • Pharmacology

Background:

  • Peripheral blood flow is influenced by local and systemic factors.
  • Studying limb blood flow in disease and drug effects presents challenges.

Purpose of the Study:

  • To compare the effects of various antihypertensive drugs on limb blood flow.
  • To assess the functional outcomes of these drugs in patients with hypertension and peripheral vascular disease.

Main Methods:

  • Comparative analysis of antihypertensive drug effects.
  • Assessment of limb blood flow and functional parameters.

Main Results:

  • The study compared the impact of several antihypertensive medications.
  • Functional effects in patients with hypertension and peripheral vascular disease were evaluated.

Related Experiment Videos

Conclusions:

  • Comparative data on antihypertensive drug effects on limb blood flow are presented.
  • Further research on novel agents like carvedilol is anticipated.